Literature DB >> 15548943

Prolonged lactation reduces ovarian cancer risk in Chinese women.

M Zhang1, X Xie, A H Lee, C W Binns.   

Abstract

To investigate the effect of lactation on the risk of ovarian cancer for Chinese women, a case-control study was conducted in Hangzhou, capital of Zhejiang province, China. Cases were 275 patients with histologically confirmed epithelial ovarian cancer. Controls were 623 women without neoplasm. All participants were parous women who had given at least one live birth and had been residents of Zhejiang province for at least 10 years. Information was collected using a validated and reliable questionnaire on total months of lactation, number of children breastfed, and average duration of lactation per child. Multivariate logistic regression models were used to assess the association between ovarian cancer risk and lactation variables, accounting for age, locality, full-term pregnancy, oral contraceptive use and family history of the cancer. The adjusted odds ratios were 0.51 (95% confidence interval (CI) 0.3-0.9) and 0.44 (95% CI 0.2-0.9) respectively for women with over 12 months of lactation and at least three children breastfed, compared with those with 4 months or less lactation and one child breastfed. The corresponding dose-response relationships were also significant (P<0.05). Therefore, prolonged lactation could reduce the risk of ovarian cancer for Chinese women.

Entities:  

Mesh:

Year:  2004        PMID: 15548943     DOI: 10.1097/00008469-200412000-00006

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  8 in total

1.  Breastfeeding and ovarian cancer risk: a meta-analysis of epidemiologic studies.

Authors:  Nan-Nan Luan; Qi-Jun Wu; Ting-Ting Gong; Emily Vogtmann; Yong-Lai Wang; Bei Lin
Journal:  Am J Clin Nutr       Date:  2013-08-21       Impact factor: 7.045

Review 2.  Use of fertility drugs and risk of ovarian cancer.

Authors:  Brenda Diergaarde; Michelle L Kurta
Journal:  Curr Opin Obstet Gynecol       Date:  2014-06       Impact factor: 1.927

3.  Use of fertility drugs and risk of ovarian cancer: results from a U.S.-based case-control study.

Authors:  Michelle L Kurta; Kirsten B Moysich; Joel L Weissfeld; Ada O Youk; Clareann H Bunker; Robert P Edwards; Francesmary Modugno; Roberta B Ness; Brenda Diergaarde
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-06-15       Impact factor: 4.254

4.  Breast-feeding and risk of epithelial ovarian cancer.

Authors:  S J Jordan; K L Cushing-Haugen; K G Wicklund; J A Doherty; M A Rossing
Journal:  Cancer Causes Control       Date:  2012-04-24       Impact factor: 2.506

5.  Breast-feeding the last born child and risk of ovarian cancer.

Authors:  Linda Titus-Ernstoff; Judy R Rees; Kathryn L Terry; Daniel W Cramer
Journal:  Cancer Causes Control       Date:  2009-11-10       Impact factor: 2.506

Review 6.  Breastfeeding and maternal health outcomes: a systematic review and meta-analysis.

Authors:  Ranadip Chowdhury; Bireshwar Sinha; Mari Jeeva Sankar; Sunita Taneja; Nita Bhandari; Nigel Rollins; Rajiv Bahl; Jose Martines
Journal:  Acta Paediatr       Date:  2015-12       Impact factor: 2.299

7.  Dads make a difference: an exploratory study of paternal support for breastfeeding in Perth, Western Australia.

Authors:  Bruce Maycock; Yvonne L Hauck; Peter Howat; Sharyn Burns; Colin W Binns; Jenny Tohotoa
Journal:  Int Breastfeed J       Date:  2009-11-29       Impact factor: 3.461

8.  Association Between Breastfeeding and Ovarian Cancer Risk.

Authors:  Ana Babic; Naoko Sasamoto; Bernard A Rosner; Shelley S Tworoger; Susan J Jordan; Harvey A Risch; Holly R Harris; Mary Anne Rossing; Jennifer A Doherty; Renée T Fortner; Jenny Chang-Claude; Marc T Goodman; Pamela J Thompson; Kirsten B Moysich; Roberta B Ness; Susanne K Kjaer; Allan Jensen; Joellen M Schildkraut; Linda J Titus; Daniel W Cramer; Elisa V Bandera; Bo Qin; Weiva Sieh; Valerie McGuire; Rebecca Sutphen; Celeste L Pearce; Anna H Wu; Malcolm Pike; Penelope M Webb; Francesmary Modugno; Kathryn L Terry
Journal:  JAMA Oncol       Date:  2020-06-11       Impact factor: 33.006

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.